KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Receivables (2016 - 2025)

Historic Receivables for Novartis Ag (NVS) over the last 13 years, with Q4 2025 value amounting to $10.1 billion.

  • Novartis Ag's Receivables rose 1828.64% to $10.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.1 billion, marking a year-over-year increase of 1828.64%. This contributed to the annual value of $10.1 billion for FY2025, which is 1828.64% up from last year.
  • Novartis Ag's Receivables amounted to $10.1 billion in Q4 2025, which was up 1828.64% from $8.5 billion recorded in Q4 2024.
  • In the past 5 years, Novartis Ag's Receivables registered a high of $10.1 billion during Q4 2025, and its lowest value of $8.4 billion during Q4 2023.
  • Its 5-year average for Receivables is $8.9 billion, with a median of $8.7 billion in 2021.
  • Per our database at Business Quant, Novartis Ag's Receivables crashed by 736.92% in 2023 and then skyrocketed by 1828.64% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Receivables stood at $8.8 billion in 2021, then increased by 2.57% to $9.0 billion in 2022, then fell by 7.37% to $8.4 billion in 2023, then increased by 1.93% to $8.5 billion in 2024, then increased by 18.29% to $10.1 billion in 2025.
  • Its Receivables was $10.1 billion in Q4 2025, compared to $8.5 billion in Q4 2024 and $8.4 billion in Q4 2023.